Investigation of therapeutic efficiency of phenytoin (PHT) labeled with radioactive 131I in the cancer cell lines
dc.contributor.author | Uzaras C. | |
dc.contributor.author | Avcıbaşı U. | |
dc.contributor.author | Demiroğlu H. | |
dc.contributor.author | Medine E.İ. | |
dc.contributor.author | Kılçar A.Y. | |
dc.contributor.author | Müftüler F.Z.B. | |
dc.contributor.author | Ünak P. | |
dc.date.accessioned | 2019-10-27T08:20:55Z | |
dc.date.available | 2019-10-27T08:20:55Z | |
dc.date.issued | 2016 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | The aim of this study is to determine the incorporations of PHT radiolabeled with 131I (131I-PHT) on U-87 MG, Daoy and A549 cancerous cell lines. For this, cold and radio-labeling studies were carried out. The radio-labeling yield of 131I-PHT was obtained about 95 %. Subsequently, cell culture studies were carried out and radio-labeling yields of 131I, 131I-PHT on U-87 MG, Daoy and A549 cancerous cells were investigated. Cell culture studies demonstrated that the incorporation values of 131I-PHT on the three cell lines decreased with increasing radioactivity. Consequently, 131I-PHT may be a good radiopharmaceutical for targeting radionuclide therapy of Central Nervous System Tumors. © 2015, Akadémiai Kiadó, Budapest, Hungary. | en_US |
dc.identifier.doi | 10.1007/s10967-015-4119-0 | |
dc.identifier.endpage | 140 | en_US |
dc.identifier.issn | 0236-5731 | |
dc.identifier.issn | 0236-5731 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 131 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s10967-015-4119-0 | |
dc.identifier.uri | https://hdl.handle.net/11454/25855 | |
dc.identifier.volume | 307 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Netherlands | en_US |
dc.relation.ispartof | Journal of Radioanalytical and Nuclear Chemistry | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Daoy and A549 cancerous cell lines | en_US |
dc.subject | Diphenylhydantoin | en_US |
dc.subject | Epilepsy | en_US |
dc.subject | Phenytoin | en_US |
dc.subject | Radiolabeling | en_US |
dc.subject | U-87 MG | en_US |
dc.title | Investigation of therapeutic efficiency of phenytoin (PHT) labeled with radioactive 131I in the cancer cell lines | en_US |
dc.type | Article | en_US |